Abstract:Cardiac fibrosis is an important pathological basis of various cardiovascular diseases. The roles of STAT6 signal in allergy, immune regulation, tumorigenesis, and renal fibrosis have been documented. However, the function and mechanism of STAT6 signal in sympathetic overactivation-induced cardiac fibrosis have not been fully elucidated. This study explores the novel role of STAT6 signal in isoproterenol (ISO)-induced cardiac fibrosis through the regulation of inflammatory response and the differentiation of macrophages from immature myeloid cells. The expression levels of STAT6, beta 1-adrenergic receptor (beta 1-AR), and inflammatory factors [interleukin alpha (IL-1 alpha), IL-6, IL-18, and transforming growth factor beta (TGF-beta)] in CD11b(+) myeloid cells were analyzed with a microarray study. The levels of IL-6 and TGF-beta 1 in the CD11b(+) myeloid cells-derived macrophages were detected with reverse transcriptase-polymerase chain reaction (RT-PCR). STAT6-knockout (KO) and WT mice were used to establish a murine cardiac fibrosis model by ISO injection. Cardiac fibroblasts were isolated from the hearts of newborn STAT6-KO and WT mice, and STAT6 expression was measured by Western blotting and RT-PCR after ISO stimulation, while alpha-smooth muscle actin (alpha-SMA) expression was detected by immunofluorescence and immunohistochemistry staining. Cardiac function and pathological characteristics were examined by echocardiography and immunohistochemistry staining, respectively. Immunohistochemistry staining with anti-CD11b was performed to detect the infiltration of CD11b(+) myeloid cells in heart tissue. Flow cytometry analysis was used to measure the percentages of CD11b(+) myeloid cells and CD11b(+)Ly6C(+) macrophages in the peripheral blood. The results showed that STAT6 was highly expressed in CD11b(+) myeloid cells located in injured hearts, and STAT6 expression in cardiac fibroblasts was down-regulated after ISO treatment. STAT6 deficiency further aggravated ISO-induced increased expression of alpha-SMA in cardiac fibroblasts, myocardial fibrosis, and cardiac dysfunction. The activation of ISO/beta 1-AR signal aggravated cardiac inflammatory infiltration, promoted CD11b(+) myeloid cell mobilization, and enhanced CD11b(+)Ly6C(+/low) macrophage differentiation, which was further exacerbated by STAT6 deficiency. Furthermore, beta 1-AR mRNA expression significantly increased in splenic CD11b(+) myeloid cells compared to their bone marrow-derived controls, and STAT6 deficiency promoted beta 1-AR expression in an MI-induced sensitive cardiac fibrosis mouse model. The spleen-derived CD11b(+) myeloid cells of STAT6-KO mice produced more IL-1 alpha, IL-18, and TGF-beta than their WT counterparts. Taken together, these results suggest that STAT6 signal plays a critical role in ISO-induced beta 1-AR overactivation and systemic inflammatory cascades, contributing to cardiac fibrogenesis. STAT6 should be a promising cardioprotective target against myocardial fibrosis and heart failure after beta 1-AR overactivation-induced myocardial injury.

Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II

Macrophage-Stimulated Cardiac Fibroblast Production Of Il-6 Is Essential For Tgf Beta/Smad Activation And Cardiac Fibrosis Induced By Angiotensin Ii

Hypoxia-stimulated Cardiac Fibroblast Production of IL-6 Promotes Myocardial Fibrosis Via the TGF- Β 1 Signaling Pathway

Reciprocal Interaction Between Macrophages and T Cells Stimulates IFN-γ and MCP-1 Production in Ang II-induced Cardiac Inflammation and Fibrosis

Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling

Serum-Glucocorticoid Regulated Kinase 1 Regulates Alternatively Activated Macrophage Polarization Contributing to Angiotensin II–Induced Inflammation and Cardiac Fibrosis

Fibroblast-derived interleukin-6 exacerbates adverse cardiac remodeling after myocardial infarction

ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice

Interleukin-6 Deficiency Attenuates Angiotensin II-induced Cardiac Pathogenesis with Increased Myocyte Hypertrophy.

Krüppel-like Factor 4 Transcriptionally Regulates TGF-β1 and Contributes to Cardiac Myofibroblast Differentiation.

Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

IL‑6 Inhibitors Effectively Reverse Post‑infarction Cardiac Injury and Ischemic Myocardial Remodeling Via the TGF‑β1/Smad3 Signaling Pathway

Disruption of STAT6 Signal Promotes Cardiac Fibrosis Through the Mobilization and Transformation of CD11b<SUP>+</SUP> Immature Myeloid Cells

The Smad3-miR-29b/miR-29c Axis Mediates the Protective Effect of Macrophage Migration Inhibitory Factor Against Cardiac Fibrosis.

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

Intracellular and extracellular Cyclophilin a promote cardiac fibrosis through TGF-β signaling in response to angiotensin II

IL-27 promotes cardiac fibroblast activation and aggravates cardiac remodeling post myocardial infarction

Interleukin-5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II-infused mice

CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY

Macrophage MKL1 contributes to cardiac fibrosis in a mouse model of myocardial infarction